Skip to main content

Table 4 Thromboelastography results of eight viscoelastic parameters assessing coagulation efficiency in naïve platelet poor plasma samples of healthy (n = 23) and T2DM (n = 25) volunteers

From: Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation

TEG clot parameters

Controls (n = 23)

T2DM (n = 25)

Adjusted OR (95% CI)

Mann–Whitney P-value

R-value (min)

9.6 [7.4 to 12.3]

7.5 [5.8 to 9.5]

0.787 (0.616, 0.969)

0.032

K-value (min)

3.75 [2.7 to 5.35]

2.15 [1.8 to 3.1]

0.765 (0.538, 1.03)

0.011

A angle (°)

61 [55.7 to 66.4]

68.1 [61.6 to 70.7]

1.06 (0.966, 1.17)

0.060

MA (mm)

23 [20.2 to 27.5]

30.3 [24.7 to 36.5]

1.12 (1.03, 1.25)

0.011

MRTG (Dyn cm−2 s−1)

3.25 [2.72 to 4.6]

5.45 [3.5 to 7.]

1.59 (1.14, 2.39)

0.014

TMRTG (min)

11.5 [8.5 to 14.7]

8.83 [7.5 to 12.2]

0.867 (0.714, 1.03)

0.100

TTG (Dyn cm−2)

149.4 [127 to 191]

218 [165 to 288]

1.01 (1, 1.02)

0.011

CI

− 4.55 [− 4.9 to − 4]

− 3.3 [− 4.1 to − 2.3]

3.44 (1.55, 10.8)

0.006

  1. Summary statistics are given as median and IQR. Significant differences are shown in italics for both models